Evidence map›Paper›PMID 34448024›Full record

Observational studyAbdominal radiology (New York)2021

Retrospective observation of the efficacy and safety of prostatic artery embolization combined with transurethral resection of the prostate and simple transurethral resection of the prostate in the treatment of large (> 100 mL) benign prostatic hyperplasia.

Yi Tang, Ruo-Li Wang, Dan-Dan Ruan, Xin Chen, Yan-Feng Zhou, Shao-Jie Wu, Sen-Lin Cai, Jian-Hui Zhang, Feng-Guang Yang, Jie-Wei Luo and 1 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Abdominal radiology (New York), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yi Tang *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Ruo-Li Wang *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Dan-Dan Ruan *Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Xin ChenShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Yan-Feng ZhouShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Shao-Jie WuShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Sen-Lin CaiShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Jian-Hui ZhangShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Feng-Guang YangShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Jie-Wei LuoShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China. docluo0421@aliyun.com.ORCID http://orcid.org/0000-0003-4271-4848
Zhu-Ting FangShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China. 470389481@qq.com.
Fujian Medical University · CNFujian University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo retrospectively compare the efficacy and safety of prostatic artery embolization (PAE) combined with transurethral resection of the prostate (TURP) and simple TURP in treating large (> 100 mL) benign prostatic hyperplasia (BPH).

methodsWe retrospectively analyzed the clinical data of 13 and 17 patients with large BPH who underwent TURP and PAE + TURP, respectively, from January 2016 to January 2020. The changes in various indices before and after surgery were compared between the two groups.

resultsIn the PAE + TURP group, the operation time (OT), intraoperative blood loss (BL), postoperative bladder flushing time (PBFT), and postoperative catheter retention time (PCRT) were lower, and the speed of the excised lesion (SEL) was higher than that in the TURP group (P < 0.05). Following-up for 12 months, the prostatic volume (PV), maximum urinary flow rate (Qmax), postvoid residual volume (PVR), International Prostate Symptom Score (IPSS), quality of life (QoL) score, total prostate-specific antigen (T-PSA), and free prostate-specific antigen (F-PSA) in each group improved as compared to before the surgery (P < 0.05), and the above improved indicators, IPSS ratio, and obstructive symptoms in the PAE + TURP group were higher than those in the TURP group (P < 0.05). The incidence of postoperative complications in the PAE + TURP group was lower than that in the TURP group. We obtained the pathological picture of a prostate biopsy after PAE for the first time.

conclusionCompared to TURP alone, PAE + TURP should be promoted, because of its greater efficacy and safety in treating large BPH and fewer post-surgical complications.

Indexed as

Embolization, TherapeuticProstatic HyperplasiaTransurethral Resection of ProstateArteriesHumansMaleQuality of LifeRetrospective StudiesTreatment OutcomeLarge prostatic hyperplasiaProstatic artery embolizationTransurethral resection of the prostate

Identifiers

PMID34448024
OpenAlexW3195483177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.